Skip to main content
. 2023 Dec 13;27(3):155–162. doi: 10.5114/wo.2023.133709

Table 5.

AKT inhibitors meeting Lipinski and Veber criteria

BindingDBReactant_set_id Name
329838 6-[4-[1-[2-(azetidin-1-yl)ethyl]-4-[4-fluoro-3-(trifluoromethyl)
phenyl]imidazol-2-yl]piperidin-1-yl]-5-(1H-pyrazol-4-yl)pyrimidin-4-amine
51061496 2-amino-6-(5-fluoro-6-methoxypyridin-3-yl)-8-[4-(hydroxymethoxy)
cyclohexyl]-4-methylpyrido[2,3-d]pyrimidin-7-one

AKT inhibitors with better affinity and interaction with mTOR than XL388 and meeting Lipinski and Veber criteria